Last €33.92 EUR
Change Today -0.125 / -0.37%
Volume 0.0
8AK On Other Exchanges
Symbol
Exchange
Frankfurt
As of 2:04 AM 04/24/14 All times are local (Market data is delayed by at least 15 minutes).

Audit Committee* - alkermes plc (8AK)

Name (Connections)Board RelationshipsTitleKey Developments
Floyd Bloom M.D. 95 RelationshipsCo-Founder, Director and Member of Audit & Risk CommitteeAlkermes Inc. Announces Securities and Exchange Commission Letter Ending Backdating Investigation
05/25/07
Paul Mitchell 7 RelationshipsLead Independent Director, Chairman of Audit & Risk Committee and Member of Compensation CommitteeAlkermes, Inc. announced delayed 10-Q filing
08/10/06
Robert Breyer 7 RelationshipsDirector, Member of Nominating & Corporate Governance Committee and Member of Audit & Risk CommitteeAlkermes, Inc. announced delayed annual 10-K filing
05/29/07

Compensation Committee* - alkermes plc (8AK)

Name (Connections)Board RelationshipsTitle
David Anstice 142 RelationshipsIndependent Director, Chairman of Compensation Committee and Member of Limited Compensation Sub Committee
Geraldine Henwood Ph.D. 21 RelationshipsDirector and Member of Compensation Committee
Paul Mitchell 7 RelationshipsLead Independent Director, Chairman of Audit & Risk Committee and Member of Compensation Committee
8AK Compensation vs. Industry
810.2K
364.2K
Chief Executive Officer
444.1K
260.9K
Chief Financial Officer
437.5K
351.4K
Chief Operating Officer
Share price activity for ALKERMES PLC (8AK)
52 Week Price Performance
8AK
Industry Average

Nominating Committee* - alkermes plc (8AK)

Name (Connections)Board RelationshipsTitleKey Developments
Wendy Dixon Ph.D. 65 RelationshipsDirector and Chairman of Nominating & Corporate Governance CommitteeAlkermes plc Announces Resignation of Mark Skaletsky from the Board of Directors
11/12/13
Robert Breyer 7 RelationshipsDirector, Member of Nominating & Corporate Governance Committee and Member of Audit & Risk CommitteeAlkermes plc Announces Board Appointments
09/30/13
Nancy Wysenski B.Sc., MBA 54 RelationshipsDirector and Member of Nominating & Corporate Governance CommitteeAlkermes plc Elects Nancy Wysenski to Board of Directors
05/16/13

Corporate Governance Committee* - alkermes plc (8AK)

Name (Connections)Board RelationshipsTitle
Robert Breyer 7 RelationshipsIndependent Director, Chairman of Compensation Committee and Member of Limited Compensation Sub Committee
Wendy Dixon Ph.D. 65 RelationshipsDirector and Member of Compensation Committee
Nancy Wysenski B.Sc., MBA 54 RelationshipsLead Independent Director, Chairman of Audit & Risk Committee and Member of Compensation Committee
8AK and Competitor
Insiders vs. External
Board
25%
75%
Alkermes plc
6%
94%
BioMarin Pharmaceutical Inc.
11%
89%
Pacira Pharmaceuticals, Inc.
3%
97%
Nektar Therapeutics
10%
90%
Jazz Pharmaceuticals Public Limited Company
40%
60%
Lupin Limited
Insiders
External Board Members
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
8AK:GR €33.92 EUR -0.125

8AK Competitors

Market data is delayed at least 15 minutes.

Company Last Change
BioMarin Pharmaceutical Inc $59.19 USD -2.80
Jazz Pharmaceuticals Plc $143.91 USD -1.44
Lupin Ltd 986.70 INR +4.10
Nektar Therapeutics $11.96 USD -0.30
Pacira Pharmaceuticals Inc/DE $68.30 USD -3.43
View Industry Companies
 

Industry Analysis

8AK

Industry Average

Valuation 8AK Industry Range
Price/Earnings 100.0x
Price/Sales 11.2x
Price/Book 6.1x
Price/Cash Flow 90.9x
TEV/Sales 10.4x
 | 

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ALKERMES PLC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.